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HIV-1 Env associates with HLA-C 
free-chains at the cell membrane 
modulating viral infectivity
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HLA-C has been demonstrated to associate with HIV-1 envelope glycoprotein (Env). Virions lacking 
HLA-C have reduced infectivity and increased susceptibility to neutralizing antibodies. Like all others 
MHC-I molecules, HLA-C requires β2-microglobulin (β2m) for appropriate folding and expression on the 
cell membrane but this association is weaker, thus generating HLA-C free-chains on the cell surface. 
In this study, we deepen the understanding of HLA-C and Env association by showing that HIV-1 
specifically increases the amount of HLA-C free chains, not bound to β2m, on the membrane of infected 
cells. The association between Env and HLA-C takes place at the cell membrane requiring β2m to 
occur. We report that the enhanced infectivity conferred to HIV-1 by HLA-C specifically involves HLA-C 
free chain molecules that have been correctly assembled with β2m. HIV-1 Env-pseudotyped viruses 
produced in the absence of β2m are less infectious than those produced in the presence of β2m. We 
hypothesize that the conformation and surface expression of HLA-C molecules could be a discriminant 
for the association with Env. Binding stability to β2m may confer to HLA-C the ability to preferentially 
act either as a conventional immune-competent molecule or as an accessory molecule involved in HIV-1 
infectivity.
During the HIV-1 budding process from the cell membrane, Major Histocompatibility Complex (MHC) class I 
and II molecules are incorporated into the virions together with other cell proteins. A higher number of MHC 
molecules than envelope (Env) trimers has been reported to be present in HIV-1 virions1. Incorporation of cell 
membrane proteins into HIV-1 envelope is not dependent on their relative amount at the cell membrane since 
some highly expressed proteins such as CD4, CD45, CCR3, CCR5 or CXCR4 are not incorporated2. It has been 
reported that MHC-I negative cell lines are not competent for the replication of primary HIV-1 isolates3 and that 
HLA-C expression in these cells rescues their HIV-1 replication competence. In addition, it was demonstrated 
that HLA-C induces changes in the viral envelope protein conformation, including an enhanced presentation of 
epitopes normally exposed upon CD4 binding3 and that HLA-C incorporation into HIV-1 virions reduces their 
susceptibility to neutralizing antibodies3. The specific association between HLA-C and Env has been confirmed in 
fusion complexes, where the recruitment of HLA-C molecules has been reported within CD4-CCR5-gp120/gp41 
complexes, formed on cells during the process of HIV-1-induced cell-to-cell fusion4. The same study demon-
strated that fusion efficiency is reduced in HLA-C negative cells and that pseudoviruses produced in HLA-C 
silenced cells are significantly less infectious than those produced in HLA-C expressing cells4. Another study 
demonstrated that HIV-1 infection of peripheral blood lymphocytes requires HLA-C expression, offering an 
explanation to the specific down-regulation of HLA-A and HLA-B, but not HLA-C, by HIV-1 Nef 5. In 2007 a 
genome wide association study (GWAS) of the major genetic determinants for HIV-1 host control identified 
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a polymorphism 35 Kb away from the HLA-C transcription initiation (− 35 SNP, rs9264942), which has been 
associated with differences in HLA-C expression levels6. Subsequently, it has been reported that the − 35 SNP 
is not the causal variant responsible for the differential HLA-C expression, but rather it is in linkage disequi-
librium with another polymorphism at position 263 downstream the HLA-C stop codon (rs67384697)7. This 
polymorphism regulates the binding of the miRNA148a to the target site. As a consequence, HLA-C surface 
expression appears lower for those alleles which bind miRNA148a, and higher for those alleles escaping this 
specific post-transcriptional regulation7. Consistent with these findings, low expression alleles such as C * 04 and 
C * 07 have been associated with a more rapid progression toward AIDS than high expression alleles, such as 
C * 02, C * 06, and C * 128. Consequently, low expression and high expression alleles are also defined as non pro-
tective and protective alleles, respectively. Cytotoxic T lymphocytes (CTLs) depletion studies in rhesus macaques 
clearly demonstrated that CTLs play a critical role in control of HIV-1 infection9. It has been proposed that higher 
HLA-C expression levels could lead to a better antigen presentation to CTLs, explaining the slower progression 
toward AIDS. In a recent work it has been demonstrated that, in most primary HIV-1 clones, Vpu is able to 
down-regulate HLA-C but not HLA-A and HLA-B, thus escaping the HLA-C restricted CTLs response, pos-
sibly depending on the prevailing host immune pressure: natural killer (NK) versus CTL10. Adding complexity 
to this matter, a recent study failed to confirm the association between HLA-C cell surface expression and the 
− 35 Kb SNP; rather, a high-allelic variability in HLA-C mRNA expression has been demonstrated, suggesting 
that the control of HLA-C expression might be more complex than expected11. MHC-I proteins are heterotri-
mers composed of a membrane-bound heavy chain, non-covalently linked to an invariant light chain, called 
β 2-microglobulin (β 2m), plus a short cytoplasmic peptide, about 8-11 amino acids long, mostly derived from the 
degradation of intracellular proteins. MHC-I molecules present these peptides to CD8+ T-cells, which survey 
the body for the presence of foreign material, killing those cells displaying pathogen-derived antigens on their 
MHC-I molecules12. Nevertheless, the amount of HLA-C at the cell surface is about 10-fold lower than that of 
HLA-A or HLA-B13, questioning its effective role in CTL-mediated responses.
HLA-C is thus involved in HIV-1 infection through different and apparently opposite mechanisms: a) the 
increase of CTLs recognition leading to the lysis of HIV-1 infected cells, b) the inhibition of NK cell recognition, 
leading to the enhancement of virion infectivity and c) the association with the HIV-1 envelope protein14.
In the present work we investigated the association between HIV-1 Env and HLA-C, demonstrating that Env 
and HLA-C free heavy chains associate at the cell surface. In addition, using the Clustered Regularly Interspaced 
Short Palindromic Repeats/CRISPR-associated Protein 9 (CRISPR/Cas9) technique to develop β 2m negative cell 
lines, we observed that the infectivity of HIV-1 Env-pseudotyped viruses is reduced in the absence of β 2m, sug-
gesting that HLA-C molecules involved with Env interaction need to be properly folded around β 2m, which then 
allows their translocation at the cell membrane.
Results
Surface expression of L31 reactive HLA-C molecules is increased in HIV-1 chronically infected 
cell lines. ACH-2 is a T-lymphocytic cell line chronically infected by HIV-1, derived from the A3.01 unin-
fected parental cell line15. HIV-1 expression can be activated in ACH-2 cells by TNF-α stimulation, through the 
induction of transcription factors binding the NF-kB site in the HIV-1 LTR region16. Both A3.01 and ACH-2 cells 
were treated with TNF-α and assessed for HIV-1 expression by flow cytometry using the anti-gp120 2G12 mono-
clonal antibody. A clear fluorescence increase was evident in ACH-2 cells, revealing a marked HIV-1 reactivation 
(Fig. 1a). Cells were stained in parallel with the DT9 antibody that recognizes HLA-C heterotrimers (HLA-C 
heavy chain, β 2m and peptide)17 and with the L31 antibody, recognizing β 2m-free HLA-C molecules18. Following 
TNF-α stimulation, cytofluorimetric analysis showed that β 2m-associated HLA-C molecules (DT9 reactive) were 
upregulated in both A3.01 and ACH-2 cells. Conversely, upregulation of HLA-C free chains (L31 reactive) was 
observed only in HIV-1-infected ACH-2 cells. As shown in Fig. 1b, L31 fluorescence in ACH-2 cells was signifi-
cantly different between TNF-α stimulated and unstimulated cells (p = 0.002), as well as towards the stimulated 
parental A3.01 cells (p = 0.01). Upregulation of DT9-reactive HLA-C molecules after TNF-α stimulation in both 
cell types is expected, since TNF-α as well as interferons are known modulators of expression of MHC-I mol-
ecules in many cell types19. Conversely the selective cell membrane increase of HLA-C free chains by HIV-1 
reactivation is an intriguing original finding. A time course analysis of HIV-1 Env, MHC-I and β 2m expression 
was conduced in A3.01 and ACH-2 cells, comparing the RFI between TNF-α stimulated and unstimulated cells 
(Fig. 2). The results showed that the expression of HLA-C free chains (L31 antibody) at the cell surface correlated 
with the expression of HIV-1 Env (2G12 antibody), both decreasing at later time points. No changes were instead 
detected in the expression of total HLA-C molecules (L31 antibody after acid wash), HLA-C heterotrimers (DT9 
antibody), MHC-I (W6/32 antibody) or β 2m (NAMB-1 antibody) molecules. The correlation between HIV-1 
infection and HLA-C free chains expression was also observed in an infection model using a different human 
T-lymphocytic cell line, PM1, chronically infected with HIV-1 III-B (Fig. 3a). PM1-IIIB cells have a constitutive 
baseline production of virus higher than ACH-2, as visualized by 2G12 staining of unstimulated cells and their 
downmodulation of MHC-I molecules (W6/32 antibody). When PM1-IIIB cells were stimulated with TNF-α , 
an increase of HLA-C free chains at the cell surface (L31 antibody) was observed (as in ACH-2 cells), which 
was barely detected in uninfected PM1 cells, further confirming a role of HIV-1 in promoting the formation of 
HLA-C free chains at the cell membrane. The mean RFI of L31 staining of three independent experiments was 3.2 
and 6.5 in TNF-α -PM1 and TNF-α -PM1-IIIB cells, respectively.
Of interest, TNF-α stimulation counteracted the downregulation of MHC-I molecules induced by HIV-1 
infection in PM1-IIIB cells. Given the correlation between increased HLA-C free chains and HIV-1 virion pro-
duction in both ACH-2 and PM1-IIIB cellular models, we sought to investigate which HIV-1 component was 
involved in this phenomenon, starting from Env. We thus transfected 293T cells with an HIV-1 Env plasmid and 
a plasmid encoding an Env defective full length HIV-1 genome (pSG3Δenv) (Fig. 3b). An increase of L31 staining 
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was detected after transfection of HIV-Env and not after transfection of the pSG3Δenv plasmid, whereas no differ-
ences were detected in L31 staining after acid wash. These data suggest that the observed increase of HLA-C free 
chains at the cell membrane is not due to an increased HLA-C expression level or membrane translocation, but 
rather it may reveal a switch in HLA-C conformation from heterotrimer to free chain on the cell membrane in the 
presence of the HIV-1 Env protein.
None of the HIV-1 proteins is responsible for the appearance of HLA-C free chains at the cell 
surface. To investigate if any of the HIV-1 proteins is instead responsible for the translocation of HLA-C free 
chains at the cell membrane, plasmids encoding Gag, Env, Vpu, Vif, Nef, Tat, as well as pSG3Δenv (containing the 
Env defective full length HIV-1 genome) were transfected in CRISPR/Cas9 β 2m knockout 293T cells. Cells were 
treated with an acid wash, before labelling with L31 antibody, in order to exclude that the potential intracellular 
association between HLA-C and any of the tested HIV-1 protein could mask the L31 epitope18. Control transfec-
tion with β 2m expressing vector increased the surface expression of HLA-C free chains, while no HLA-C upregu-
lation was detected on the membrane of cells transfected with all the HIV-1 proteins encoding constructs (Fig. 4). 
Moreover, we prepared β 2m knockout variants of both HeLa and HeLa-Lai cell lines using the CRISPR/Cas9 
technique. Both parental and β 2m negative cells were analysed by flow cytometry for the presence of HLA-C free 
chains at the cell surface using the L31 antibody (Fig. 5). We observed that both HeLa and HeLa-Lai β 2m negative 
cells lacked the expression of HLA-C at the cell membrane, indicating that the presence of HIV-1 Env in HeLa-Lai 
was not sufficient for HLA-C translocation, which strictly requires β 2m for MHC-I assembly and transportation 
to the surface, where the presence of Env might favour the formation of HLA-C free chains.
HIV-1 Env and HLA-C interaction: BiFC assay. Previous studies demonstrated the association between 
Env and HLA-C3,4. To analyse Env and HLA-C interaction, the Bimolecular Fluorescence Complementation 
(BiFC) assay was exploited. BiFC assay is based on the association between two non-fluorescent fragments of 
a fluorescent protein which have low affinity for each other, but when they are fused to interacting proteins, 
the fluorophore is reconstituted and a fluorescent signal is produced by bimolecular complementation20. Several 
constructs were developed, cloning the N- and C- terminal fragments (Yn and Yc) of the Yellow Fluorescent 
Protein (YFP) to the C-terminus of Env and HLA-C proteins. The system was validated in HeLa cells, assess-
ing the complementation between Jun-Yn and Fos-Yc, which resulted in a green signal in the nucleus (Fig. 6a), 
as previously described21. Since it is known that Fos is efficiently translocated from cytoplasm to the nucleus 
only after interacting with Jun through their leucine zippers and by the use of the nuclear localization signal of 
Figure 1. Cytofluorimetric analysis of A3.01 and ACH-2 cell lines. (a) Dashed line: negative control 
(secondary antibody fluorescence); thin line: unstimulated cells; thick line: cells stimulated with TNF-α for 
24 h. 2G12, DT9 and L31 antibodies detect HIV-1 Env, HLA-C heterotrimers and HLA-C free chains at the cell 
membrane, respectively. Following TNF-α stimulation, ACH-2 cells express HIV-1 Env glycoprotein (2G12 
antibody); HLA-C heterotrimers are upregulated in both cell types (DT9 antibody); HLA-C free chains are 
upregulated only in ACH-2 cells (L31 antibody). (b) ○: unstimulated A3.01 cells; ●: TNF-α stimulated A3.01 
cells; △: unstimulated ACH-2 cells; ▲: TNF-α stimulated ACH-2 cells. Data from 6 independent experiments 
are shown as mean fluorescence intensity (MFI) of L31 staining. L31 fluorescence results to be significantly 
different between TNF-α stimulated ACH-2 cells (chronically infected by HIV-1) and A3.01 cells (parental cell 
line, uninfected) (p = 0.01), and between TNF-α stimulated and unstimulated ACH-2 cells (p = 0.002). p values 
were calculated by two-way ANOVA comparing ACH-2-TNF-α with A301-TNF-α and ACH-2-TNF-α with 
ACH-2-unstimulated.
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Jun22, the nuclear BiFC signal confirms the Fos/Jun association. For the same reason when Fos-Yc, which in the 
absence of Jun localizes in the cytoplasm, was co-transfected with Env-Yn and the result was a BiFC negative 
signal (Fig. 6b). Finally, HeLa cells were co-transfected with Env-Yn and Env-Yc and stained with the anti-β 2m 
antibody (red signal). The BiFC green signal was detected at the plasma membrane, due to Env-Env interaction 
(Fig. 6c,e)23. Similarly, co-transfection of Env-Yn and HLA-C-Yc reconstituted the YFP fluorophore at the cell 
membrane (Fig. 6d,f). All the z-stacks from a single cell were further investigated (see Supplementary Movie 
S1). The BiFC green signal was not widespread, but rather polarized in specific membrane clusters. The Env/
HLA-C complex did not appear to co-localize with β 2m, indicating that HLA-C molecules may associate at the 
cell membrane either with Env or with β 2m, resulting in green or red fluorescence, respectively. The absence of 
a clear co-localization signal suggests that the association between Env and HLA-C involves HLA-C free chains.
HIV-1 Env interacts with HLA-C at the cell membrane. To further investigate the association 
between Env and HLA-C at the cell membrane, HeLa-Lai cells were treated with the cell membrane insolu-
ble, thiol-cleavable DTSSP reagent24, which was used to crosslink protein complexes at the cell surface. Proteins 
were purified on a GN lectin column25 which specifically binds D-mannose groups present on the HIV-1 
Env glycoprotein and several fractions were obtained by elution with increasing concentrations of methyl 
α -D-mannopyranoside. Purified complexes heavier than 100 kDa were analysed by western blot after reduction 
(Fig. 7a). As a negative control, identical amounts of proteins from HeLa cells were analysed following the same 
procedure. To exclude any excessive cross-linking of membrane proteins due to DTSSP treatment, flotillin-1, a 
membrane protein, was tested: no specific copurification in the presence of HIV-1 Env was observed, and no 
differences in its purification were detected between the two cell lines. HLA-C molecules produced in HeLa 
cells were eluted in the first fractions as they contain few mannoses26, whereas HLA-C molecules produced in 
HeLa-Lai cells were co-purified, in parallel with Env, in higher amounts and in all the fractions. In addition, 
co-immunoprecipitation of protein complexes from the cell surface of both Hela and HeLa-Lai cells with the 
2G12 antibody (anti-Env), further confirmed the association between Env and HLA-C (Fig. 7b), in agreement 
Figure 2. Time course expression analysis of HIV-1 Env, MHC-I and β2m in TNF-α stimulated and 
unstimulated A3.01 and ACH-2 cells. Cells were stained after 3, 24, 48 and 72 h of culture. Solid line: 
ACH-2 HIV-1 infected cells; dotted line: parental A3.01 cells. RFI (Relative Fluorescence Intensity) = (Mean 
Flourescence Intensity (MFI) sample − MFI control)/MFI control. Data are shown as fluorescence fold change 
between RFI of TNF-α stimulated and unstimulated cells. The presence of HLA-C free chains at the cell 
surface appears to be dependent on the presence of HIV-1 Env; expression of both Env and HLA-C free chains 
decreases at later times (48 and 72 h post TNF-α stimulation, panel 2G12 for Env and panel L31 for HLA-C 
free chains). No changes in the expression of total HLA-C (L31 AW panel, after an acid wash to remove β 2m), 
HLA-C heterotrimers (DT9 panel), MHC-I (W6/32 panel) or β 2m (NAMB-1 panel) are observed.
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with previously reported data3. Incubation with the DT9 antibody did not result in Env immunoprecipitation, 
excluding the involvement of HLA-C heterotrimers in the association with Env. Overall, these results indicated 
that HLA-C free chains are co-purified with Env at the cell membrane.
Figure 3. HIV-1 Env expression correlates with HLA-C free chains upregulation. (a) Black line: negative 
control (secondary antibody fluorescence); blue line: PM1 unstimulated cells; red line: PM1 cells stimulated 
with TNF-α for 48 h. In the absence of stimulation, HIV-1 (IIIB strain) infection (2G12 staining) induces the 
downregulation of MHC-I molecules (W6/32 staining) and a slight increase of HLA-C free chains molecules at 
the cell surface (L31 staining), compared to the uninfected cells. After TNF-α stimulation, the HIV-1 replication 
is increased and the expression of MHC-I molecules at the cell membrane is restored. The increased HIV-1 Env 
expression correlates with a higher presence of HLA-C free chains molecules at the cell surface of the infected 
cells, compared to the uninfected ones. (b) Shaded curve: negative control (secondary antibody fluorescence); 
black line: 293T transfected with pcDNA3 (Mock); blue line: 293T transfected with pSG3Δenv; red line: 293T 
transfected with HIV-1 QHO-Env plasmid. L31 staining indicates an increase of HLA-C free chains at the cell 
membrane of cells transfected with HIV-1 Env, compared to the the transfection with pcDNA3 or pSG3Δenv 
plasmids. On the contrary, after acid wash (L31 AW) no differences in the amount of total HLA-C molecules 
were detected.
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6Scientific RepoRts | 7:40037 | DOI: 10.1038/srep40037
Functional effect of β2m on HIV-1 infectivity. Previous results showed that HIV-1 envelope glycopro-
tein specifically associates with HLA-C, improving the ability of virions to infect target cells4. To discriminate the 
role of β 2m in virion infectivity, Env-pseudotyped viruses (QHO and pRHPA) were produced in parental 293T 
and in CRISPR/Cas9 β 2m negative 293T cells. An infectivity assay was performed with TZM-bl cells, in which the 
luciferase expression signal reflects virus infectivity27. Equivalent amounts of pseudoviruses, determined by p24 
titration, were used. Luciferase expression resulted significantly higher following infection with pseudoviruses 
originating from 293T-β 2m positive cells than with the ones derived from 293T-β 2m negative cells (p < 0.0001) 
(Fig. 8). Analysis of the interpolating curve, best fitting the Relative Luminescence Units (RLU) values, indicated 
that in the absence of β 2m, the virus was about 3 times less infectious. No difference in infectivity was observed 
Figure 4. Cytofluorimetric analysis of β2m negative 293T cells, after transfection with different HIV-1 
genes. Shaded curve: negative control (secondary antibody fluorescence); red line: L31 labelled cells. After 
transfection with plasmids encoding different HIV-1 proteins, cells were labelled with the L31 antibody, after 
acid wash. As a positive control cells were transfected with β 2m. Cytofluorimetric analyses indicate that only  
β 2m transfection is able to restore HLA-C at the cell membrane of β 2m negative cells. Neither the presence of 
Env, nor the presence of other HIV-1 proteins is sufficient to translocate HLA-C to the cell surface.
www.nature.com/scientificreports/
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using Vesicular Stomatitis Virus (VSV) G protein pseudotyped viruses produced in both 293T cells types. These 
results suggested that β 2m increases HIV-1 infectivity ensuring HLA-C translocation at the cell surface, where the 
association with Env occurs.
Discussion
HLA-C molecules are selectively incorporated into the HIV-1 envelope during virus budding from the host cell 
membrane2. Several evidences of the interaction between Env and HLA-C indicate that the presence of HLA-C is 
necessary to facilitate HIV-1 infection. The two molecules have been found associated and in the absence of 
HLA-C both fusion efficiency and virus infectivity are reduced3–5. In this work, a significant up-regulation of 
surface-HLA-C free chains, reactive to the L31 antibody18 was observed in HIV-1 chronically infected cells 
(ACH-2) following virus reactivation by TNF-α stimulation. This was not observed in the corresponding unin-
fected parental cell line (A3.01). On the contrary, cellular staining with the DT9 antibody, which detects HLA-C 
heterotrimers17, did not reveal any difference between the two cell lines, suggesting that HIV-1 reactivation selec-
tively enhances HLA-C free chains expression at the cell surface. Moreover, the amount of HLA-C free chains at 
the cell surface correlated with the expression of HIV-1 Env, decreasing after 48 and 72 h from TNF-α stimula-
tion. On the contrary, no differences in the cell membrane expression of total HLA-C molecules, HLA-C hetero-
trimers, MHC-I or β 2m were detected, indicating that HIV-1 infection may preferentially increase the amounts of 
HLA-C free-chain conformation. This observation was further confirmed in another cell line (PM1), where the 
TNF-α -induced increase of HIV-1 replication correlated with the upregulation of HLA-C free chains at the cell 
membrane. In addition we observed that Env-transfected 293T cells expressed more HLA-C free chains on their 
membrane than 293T cells transfected with the Env defective full length HIV-1 genome (pSG3Δenv plasmid), 
suggesting that Env may promote the formation of HLA-C free chains at the cell surface. HIV-1 infection does not 
directly cause upregulation of HLA-C, neither at the expression level nor by modulating its stability or membrane 
translocation. We hypothesize that the presence of HIV-1 Env favours the dissociation of β 2m from HLA-C, thus 
resulting in a higher amount of HLA-C free chain molecules at the plasma membrane, but this point requires 
further investigation. β 2m is essential to translocate HLA-C at the cell surface, where β 2m light chain might disso-
ciate from HLA-C heavy chain and the association of HLA-C free chain with Env may take place. β 2m is necessary 
for ensuring HLA-C translocation at the cell surface, indicating that HLA-C molecules strictly require β 2m for 
reaching the plasma membrane, following the classical MHC-I pathway and that neither the presence of Env, nor 
the presence of other HIV-1 proteins, is responsible for HLA-C free-chains translocation. Our results with the 
BiFC technique provided experimental evidence of a very close association between Env and HLA-C free chains 
at the cell membrane. The association was further confirmed both by proteins purification on GN lectin columns 
after membrane proteins crosslinking and by co-immunoprecipitation of membrane protein complexes from 
Hela and HeLa-Lai cells. HLA-C molecules are characterized by a post-translational biosynthetic bottleneck due 
Figure 5. The presence of HLA-C free-chains at the cell membrane is dependent on β2m expression. 
(a) L31 labelling, after acid wash, indicates that both HeLa and HeLa-Lai β 2m negative cells (β 2m− ) are 
unable to express HLA-C molecules at the plasma membrane while the parental cell lines (β 2m+ ) normally 
translocate HLA-C to the cell surface. The error bars represent standard errors from the mean calculated from 
quadruplicate determinations. (b) Shaded curve: negative control (secondary antibody fluorescence); dashed 
line: β 2m− cells; solid line: β 2m+ cells. HLA-C membrane expression is detected only in the parental β 2m 
positive cells.
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to an inefficient assembly with the peptide, which leads to accumulation in the endoplasmic reticulum of both 
β 2m-free and β 2m-associated folding intermediates28. This may be the reason why HLA-C could more easily dis-
sociate from β 2m compared to HLA-A and -B. Due to their long half-life, MHC-I free chains have been shown to 
cis-associate both with themselves and with a variety of membrane receptors, such as CD3, CD8α β , CD25, Ly49A 
Figure 6. BiFC assay between Env and HLA-C in HeLa cells. (a) Nuclear complementation between Jun-Yn 
and Fos-Yc was assessed as a positive control (green signal). (b) Complementation between Env-Yn and Fos-Yc 
was assessed as a negative control. (c,e) Transfection of Env-Yn and Env-Yc leads to the BiFC signal (green), 
indicating Env oligomerization at the cell membrane. (d,f) Transfection of Env-Yn and HLA-C-Yc leads to 
the BiFC signal (green) indicating the Env/HLA-C interaction at the cell membrane. In panels c and d β 2m is 
labelled in red.
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and IL-15Rα 2,29–31. It is therefore plausible that HLA-C free chains may also have the propensity to associate with 
Env. Since β 2m is essential for the assembly of MHC-I molecules and their translocation to the plasma membrane, 
we investigated the role of β 2m in HIV-1 infectivity. In particular, we perfomed an infectivity assay in TZM-bl 
cells, demonstrating that the infectivity of HIV-1 pseudoviruses produced in β 2m negative 293T cells was roughly 
3 times lower than the infectivity of pseudoviruses produced in the corresponding β 2m positive parental 293T 
cells. A similar 3-fold reduction in HIV-1 infectivity was also reported by Cosma et al.3. Our data are also sup-
ported by previous data showing that silencing of HLA-C expression significantly reduces HIV-1 infectivity4. This 
result further confirms the involvement of HLA-C in increasing HIV-1 infectivity4, indicating that β 2m is essential 
for the translocation of HLA-C to the cell surface where, after β 2m dissociation, HLA-C free chains might associ-
ate with Env. However, since β 2m knockout in 293T cells also highly affects the expression of other classical and 
non-classical HLA-Class I molecules, the observed reduction in infectivity of the virions may not be exclusively 
due to the absence of HLA-C on the cell surface. The experiments described, together with previously reported 
data3–5, demonstrate that HLA-C interacts with Env; in particular in this study we showed that the enhanced 
infectivity conferred to the virus by HLA-C, previously reported by our group4, involves HLA-C free chains. 
Overall, the data presented in this work support the hypothesis that HLA-C involvement in HIV-1 infection may 
confer some advantages to the virus. HLA-C may be involved in several HIV-1 processes, such as improving the 
virion assembly process, reducing the shedding of viral glycoproteins from the cell membrane, stabilizing, 
through a cis-interaction, the Env proteins on the virion in a favourable conformation for cell attachment and 
fusion. The presence of HLA-C also reduces HIV-1 virions susceptibility to neutralizing antibodies3. On the other 
hand, it has been reported that HLA-C is involved in the immune control of HIV-1 infection, contributing to 
Figure 7. Env and HLA-C are associated at the cell surface. (a) HeLa and HeLa-Lai cells were treated with 
the cell membrane insoluble DTSSP cross-linker. Proteins were purified on GN lectin columns by elution with 
increasing concentrations (from 0.25 to 1 M) of methyl α -D-mannopyranoside. Purified complexes heavier 
than 100 kDa were analysed by western blot. Env purification is evident in HeLa-Lai cells and not in control 
HeLa cells. HLA-C molecules, containing few mannoses, are eluted in the first fractions from HeLa cells, 
while they are co-purified in higher amounts in the presence of Env (HeLa-Lai). No differences in flotillin-1 
purification, used as negative control, were detected. (b) Membrane protein complexes from HeLa and HeLa-
Lai cells were immunoprecipitated with 2G12 (anti-Env), DT9 (anti-HLA-C) and a-β 2m (anti-β 2m) antibodies. 
Western blot analysis of immunoprecipitated samples shows that HLA-C is associated either with β 2m or with 
Env. HLA-C and α /β -tubulin expression were detected as loading control.
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recognition by CTLs and lysis of HIV-infected cells. Protective genotypes have been correlated with high levels of 
HLA-C surface expression6,32: higher HLA-C surface expression has been associated with a stronger control of 
viral load33. A recent study34 reported that the different amounts of surface-expressed HLA-C is dependent on the 
allelic variant and confirmed the correlation between high HLA-C levels and control of HIV-1 viremia. However, 
HLA-C does not efficiently present antigen to CTLs, while it is an extremely good ligand for KIR receptors, pro-
tecting target cells from lysis mediated by NK cells35. This may imply that other properties and functions of 
HLA-C alleles could be involved14. Recently, the relation between HLA-C alleles and expression levels has been 
questioned by a study in which the reported association between HLA-C cell surface expression and the − 35 Kb 
polymorphism was not confirmed. Rather a high-allelic variability in HLA-C mRNA expression was reported11. 
The protective role of highly expressed alleles towards infection is in apparent contrast with our results, which 
show a role for the Env/HLA-C association in enhancing viral infectivity. Interestingly, in this work we showed 
that the interaction between HIV-1 and HLA-C selectively involves HLA-C free chains (L31 reactive). HLA-C 
expression observed by Apps et al.34 was assessed using a different antibody (DT9), which recognizes 
β 2m-associated HLA-C and cross-reacts with HLA-E36. In our study, the L31 antibody, specific for the HLA-C free 
chains, allowed the definition of the HLA-C conformation as an important discriminatory factor for the associa-
tion with HIV-1 Env. This may confer to HLA-C allelic variants a selective capacity to function as accessory 
molecules in the process of virus assembly and budding14. Differences reported among HLA-C alleles might rely 
on intrinsic differences in their lower or higher ability to bind β 2m. It is known that murine MHC- I molecules 
show allelic differences in their interaction with β 2m37. In addition, it should be taken into consideration the pos-
sibility that HIV-1 could have the capacity to directly displace β 2m from HLA-C and/or bind β 2m, as previously 
reported for CMV38. β 2m has been detected on HIV-1 virions39, as well as on HTLV-I40, echoviruses41 and cox-
sackievirus42 viral particles. β 2m bound to these viruses is involved in modulating viral infectivity as well as in 
conferring protection from neutralizing antibodies. Furthermore, β 2m bound to HIV-1 virions is recognized by a 
specific antibody, R7V, which neutralizes different HIV-1 isolates but does not bind to the cell surface; this epitope 
appears to be exposed only when β 2m is bound to HIV-1 particles43. In conclusion, the alternative conformations 
of HLA-C may directly affect the balance between protection and susceptibility outcome. In particular, its preva-
lence at the cell membrane either as heterotrimer or as free chain could determine whether HLA-C is more 
advantageous to the host or to the virus, respectively. Despite differences in the expression of HLA-C alleles do 
exist, due to the action of redundant regulatory mechanisms, a common feature is the poor HLA-C assembly28. 
This conformational instability suggests that HLA-C allotypes weakly binding β 2m might be mainly present as 
free chains, resulting in a selective propensity for association with other proteins, including HIV-1 Env. The sta-
bility of different HLA-C alleles was assessed in a previous work by measuring the relative abundance of both free 
and β 2m-associated HLA-C molecules at the plasma membrane28. A correspondence may be observed between 
highly expressed alleles, according to Apps’ definition34, and a more stable association with β 2m, and between low 
expressed alleles and prevalence as free chains. In particular, low expressing alleles, such as C * 04 and C * 07, 
showed a strong prevalence as L31-reactive free chains, while high expressing alleles, such as C * 06 and C * 08, 
showed an increased β 2m-association, detected with the W6/32 antibody28. A complete characterization of 
HLA-C conformations on infected cells is required, in relation to their expression level. We are currently attempt-
ing to investigate if the different amounts of HLA-C detected at the cell membrane may also be attributed to dif-
ferent predominant conformations. Different HLA-C alleles should also be evaluated for possible differences in 
Figure 8. Luciferase-based HIV-1 pseudoviruses infectivity assay on TZM-bl cells. Pseudoviruses 
produced in parental 293 T β 2m+ cells (solid line) are significantly more infectious than those produced in 
293 T β 2m− cells (dotted line). This is observed for two HIV-1 Env pseudotyped viruses (QHO and pRHPA) 
(p < 0.0001) and not for an unrelated pseudotyped virus (VSV-G). Data are expressed as Relative Luminescence 
Units (RLU). The error bars represent standard deviations from the mean calculated from quadruplicate 
determinations. p values were calculated by two-way ANOVA, comparing β 2m+ and β 2m− pseudoviruses.
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the interaction with HIV-1 Env. This study suggests that HLA-C expression may go beyond its immunological 
role; rather it could have a deeper implication during HIV-1 infection. Our results help to elucidate the interac-
tion between HLA-C and Env and provide new insights into the complex role played by HLA-C in HIV-infection. 
The understanding of this interaction may assist in the design of new therapeutic strategies aimed at controlling 
HIV-1 infection.
Methods
Cell lines. HeLa and 293T cells were obtained from the American Type Culture Collection (ATCC). HeLa-Lai 
cells were kindly provided by Dr. Uriel Hazan, Institut Cochin, Paris, France. Briefly, these cells were obtained 
by transfection of a HIV-1 provirus in which gag and pol genes were deleted, while nef was replaced by the dhfr 
drug resistance44. TZM-bl cells were provided by the EU Programme EVA Centre for AIDS Reagents, NIBSC 
(ARP5011)45. A3.0146 is a CD4+ T-lymphoma cell line, from which the HIV-latently infected cell line (ACH-2) 
has been derived by in vitro infection with HIV-1 IIIB. The viral expression is induced in ACH-2 cells by stim-
ulation with TNF-α 16,47,48. PM1 (from Dr. P. Lusso, AIDS Research and Reference Program, Division of AIDS, 
NIAID, NIH, USA) is a clonal derivative of the human T lymphocytic HUT 78 cell line and PM1-IIIB is the 
chronically-infected counterpart. All the cell lines were grown at 37 °C in a humidified atmosphere with 5% CO2. 
HeLa, HeLa-Lai, 293T, TZM-bl cell lines were cultured in Dulbecco’s modified Eagle’s medium, high glucose 
(Euroclone), while A3.01, ACH-2 and PM1 cell lines were cultured in RPMI-1640 medium (Euroclone). Culture 
medium was supplemented with 10% FBS, 2 mM L-Glutamine, 100 U Penicillin/ml and 100 U Streptomycin/ml 
(Lonza).
Vectors. Plasmids coding for HIV-1 Env, R5 strain QHO (ARP2043, Dr. D. Montefiori and Dr. F. Gao)27 and 
R5 transmitted/founder strain pRHPA (ARP2061, Dr. B. H. Hahn and Dr. J. F. Salazar-Gonzalez)27 were provided 
by the EU Programme EVA Centre for AIDS Reagents, NIBSC (Courtesy of NIH AIDS Research and Reference 
Reagent Programme), as well as the pCV1 plasmid, encoding for HIV-1 Tat (ARP2004, Dr. F. Wong-Staal)49. 
The pSG3Δenv backbone plasmid (catalogue number 11051, Dr. J. C. Kappes and Dr. X. Wu)50, the plasmids 
encoding HIV-1 Vif (pcDNA-HVif, catalogue number 10077, Dr. S. Bour and Dr. K. Strebel)51 and the HIV-1 
Gag (catalogue number 11468, Dr. M. D. Resh and G. Pavlakis)52 were obtained from the NIH AIDS Research 
and Reference Reagent Program. The plasmid encoding the 91US005 HIV-1 Env was prepared as previously 
reported53. The plasmid expressing the HLA-C (pZeo-HLA-C) was provided by Prof. A. Siccardi (Ospedale San 
Raffaele, Milan, Italy), while plasmids encoding Nef and Vpu were kindly provided by Dr. M. Pizzato (CIBIO, 
Trento, Italy)54. Plasmids expressing the VSV-G protein (pCMV-VSV-G) and the human β 2m-microglobulin 
(pBJ1-human β 2m) were purchased from Addgene, as well as the pSpCas9(BB)-2A-Puro (PX459) V2.0 vector. The 
plasmid pCR-Blunt II-TOPO encoding the β 2m gRNA (crB2M_13) was provided by Dr. C.A. Cowan (Harvard 
University, MA USA)55. Jun-Yn and Fos-Yc plasmids were provided by Prof. Tom K. Kerppola (University of 
Michigan, Ann Arbor, MI USA).
Antibodies. The human 2G12 (EVA3064, Dr. D Katinger)56 and the mouse CA13 (ARP3119, Ms. C Arnold) 
antibodies were provided by the EU Programme EVA Centre for AIDS Reagents, NIBSC; the L3118, the W6/3257 
and the NAMB-1 antibodies58 were kindly provided by Dr. P. Giacomini (Regina Elena Hospital, Rome, Italy); 
the DT9 antibody17 was a kind gift from A. Fenton-May and P. Borrow (Nuffield Dept. of Clinical Medicine, 
University of Oxford, UK). The rabbit anti-β 2m (ab15976) and the rabbit anti α /β -tubulin (# 2148) antibodies 
were purchased from Abcam and Cell Signaling, respectively. The mouse anti-flotillin-1 antibody (# 610821) 
was available from BD Transduction Laboratories. As secondary antibodies, the Alexa Fluor 488 conjugated 
goat anti-human (Southern Biotech), the phycoerythrin-conjugated anti-mouse (Southern Biotech), the Alexa 
Fluor 488-conjugated goat anti-mouse (Cell Signaling), the Texas red-labelled sheep anti-rabbit (Abcam) and the 
HRP-conjugated anti-mouse (Promega) were used.
Transfections. Cells were transfected with the TransIT-LT1 transfection reagent (Mirus Bio), following man-
ufacturer’s instructions. GFP expression was assessed as a transfection efficiency control.
Development of β2m knockout cell lines by CRISPR/Cas9. 293T, HeLa and HeLa-Lai cells were 
co-transfected with the pCR-Blunt II-TOPO β 2m gRNA55 and the pSpCas9 vectors. After puromycin selection, 
β 2m negative cells were labelled with the NAMB-1 antibody and sorted using a FACSAria II cell sorter (BD 
Biosciences, San Josè, CA).
Flow cytometry analyses. A3.01, ACH-2 and PM1 cells were cultured either in the absence or in the pres-
ence of TNF-α (10 ng/ml) for the indicated time points. Cells were stained for 30 minutes at 4 °C with 2.5 μ g/ml 
of DT9, 1 μ g/ml of L31 and W6/32, 5 μ g/ml of 2G12 and 1:200 dilution of ascitic fluid for NAMB-1. After PBS 
washes, cells were labelled with phycoerythrin-conjugated anti-mouse or Alexa Fluor 488 conjugated anti-human 
antibodies. Cells were fixed with 1% formaldehyde prior to acquisition with a Gallios flow cytometer (Beckman 
Coulter) and analysed using the FlowJo software (TreeStar, San Carlos, CA). Data for the time course analysis 
between TNF-α stimulated and unstimulated A3.01 and ACH-2 cells were expressed as fluorescence fold change 
between RFI (Relative Fluorescence Intensity) of TNF-α stimulated and unstimulated cells. β 2m negative 293 T 
cells (transfected with the different HIV-1 plasmids), as well as parental and β 2m negative HeLa and HeLa-Lai 
cells, were labelled with 1 μ g/ml of L31 antibody for 30 minutes at 4 °C, followed by staining with Alexa Fluor 
488-conjugated goat anti-mouse antibody. Data were acquired with a FACSCanto flow cytometer (BD Bioscience) 
and analysed using the FlowJo software (TreeStar, San Carlos, CA). For HLA-C free chains determination (L31 
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acid wash), cells were treated with RPMI-1640, 20% FBS, pH 2.5 for 3 minutes in ice to displace β 2m, prior to 
washes and staining with L31.
Env-Yc, Env-Yn, HLA-C-Yc, HLA-C-Yn BiFC constructs. The Env-Yn, Env-Yc, HLA-C-Yn, HLA-C-Yc 
constructs were prepared from Env and HLA-C sequences from the 91US005 Env53 and pZeo-HLA-C plas-
mid, respectively. Gene sequences were amplified by PCR with a forward primer harbouring XbaI restriction 
site (HLA-C: CACCTCTAGAATGCGGGTCATGGCGCCCCG; Env: TCTAGAATGGCAGGAAGA 
AGCGGAGAC) and a reverse primer, abolishing the protein stop codon, harbouring XhoI restriction 
site (HLA-C: CGACTCGAGTCGGCTTTACAAGCGATGAG, Env: TCCCTCGAGCCAGCCCTGT 
AAATTCTTTGTATT). HLA-C and Env amplification products were cloned in pcDNA 6.2 plasmids (Invitrogen), 
upstream either the YFP N-terminus (Yn) or the YFP C-terminus (Yc). The Yn and the Yc fragments were 
obtained by PCR amplification of YFP from pcDNA6.2/N-YFP plasmid (Invitrogen) with primer pairs 
harbouring EcoRI restriction sites (Yn fragment: Fw: TGAGAATTCATGGTGAGCAAGGGCGAG, Rv: 
ACTGAATTCTTACTGCTTGTCGGCCATGATA; Yc fragment: Fw: CAGGAATTCAAGAACGGCA 
TCAAGGTG, Rv: ACTGAATTCTTACTTGTACAGCTCGTCCATG) to allow cloning in pcDNA6.2. Each con-
struct was verified by sequencing.
Bimolecular Fluorescence Complementation (BiFC) assay. HeLa cells were transfected with BiFC 
constructs and then switched to 30 °C for 2 hours to allow the fluorophore maturation21. Cells were fixed with 
4% paraformaldehyde and labelled with the anti-β 2m antibody (Abcam). After PBS washing, cells were incu-
bated with Texas red-labelled sheep anti-rabbit antibody and nuclei were stained with Hoechst. Coverslips were 
mounted with Dako fluorescence mounting medium. The images were captured using a confocal laser-scanning 
fluorescence microscope Leica TCS SP5 and analysed with the LAS AF software (Leica). For each experiment, the 
Jun-Yn and Fos-Yc complementation was assessed as a positive control21, while the complementation of Fos with 
either HLA-C or Env was tested as a negative control.
Env/HLA-C co-purification. HeLa and HeLa-Lai cells were fixed with 1 mM DTSSP (ThermoScientific) 
according to manufacturer’s instructions. Cells were washed with PBS and resuspended in lysis buffer (2.5 mM 
Hepes, 145 mM NaCl, 1% Triton, 0.1 mM PMSF). The cell lysate was centrifuged to pellet nuclei and the super-
natant was passed over a snowdrop lectin column (Galanthus nivalis lectin, Sigma)25,59, previously equilibrated 
with dialysis buffer (2.5 mM HEPES, 145 mM NaCl, pH 7.4, and 0.1% Triton). Proteins were collected in five 
elution fractions containing increasing concentrations (0.25, 0.40, 0.55, 0.70 and 1 M, one column volume) of 
methyl α -D-mannopyranoside (Sigma). Each eluted fraction was concentrated using a 100 KDa Amicon Ultra 
Centrifugal Filter (Millipore). Lysate (25 μ g), not bound (25 μ g) and 1/4 of the total volume of concentrated frac-
tions were incubated for 10 minutes at 98 °C in the presence of 3% β -Mercaptoethanol, to cleave the DTSSP thiol 
links, and then analysed by western blot.
Co-immunoprecipitation of protein complexes at the cell surface. Co-immunoprecipitation was 
performed as previously described60. Briefly, HeLa and HeLa-Lai cells were labelled at the cell surface with 2G12, 
DT9, or anti-β 2m (Abcam) antibodies, for 45 minutes at 4 °C. After PBS washing, cells were resuspended in 0.5% 
NP-40 non-denaturing lysis buffer. Cellular nuclei were removed by centrifugation at 3000 rpm for 3 minutes. 
Cell surface labelled proteins complexes were incubated at 4 °C with Dynabeads® protein G (Life Technologies) 
for 45 minutes. Beads were washed and resuspended in elution buffer containing 2% SDS and 40 mM DTT. After 
boiling at 98 °C, proteins were separated by SDS-PAGE and analysed by western blot.
Western blot analysis. Immunoblot analysis was performed using the CA13 (1:200) for HIV-1 Env, the L31 
(1:200) for HLA-C, the anti-flotillin-1 (1:500) or the anti-α /β -tubulin (1:2000) antibodies, followed by incubation 
with HRP-conjugated anti-mouse or anti-rabbit antibodies. The signal was developed using the ECL AdvanceTM 
Western Blotting Detection Kit (Amersham), through the AutoChemi System UVP (BioImaging System).
Production of Env-pseudotyped viruses and TZM-bl assay. Pseudoviruses expressing the Rev/Env 
sequences of different HIV-1 subtype-B strains (QHO and pRHPA) were produced by co-transfecting 293 T cells 
with the pSG3Δenv backbone plasmid and collecting the pseudoviruses-containing supernatant after 48 hours, 
as previously described27. VSV-G was used as a control. Pseudoviruses were quantified using the p24 ELISA kit 
(Aalto Bio Reagents Ltd, Dublin, Ireland) and the same amount of virus was used to infect 1 × 104 TZM-bl cells 
in the presence of 20 μ g/ml DEAE-dextran27. Luminescence was measured 48 hours later, using the VictorTM3 
luminometer (Perkin Elmer). Each assay was performed in quadruplicate.
Statistical analysis. Results were analysed using two-way ANOVA using StataMP 13.0 (Stata Corp. 2013, 
College Station, TX, USA). A significance level of p < 0.05 was accepted as statistically significant.
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